MedTrace Logo

Motor Imagery Plus Therapeutic Exercise in Women With Menstrual Pain

NCT06674655 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-05-19

No results posted yet for this study

Summary

The researchers will conduct a study that combines motor imagery with therapeutic exercise in women experiencing menstrual pain. Previous research suggests that motor imagery, when used alongside physical exercise, may help improve motor control and alleviate pain, potentially enhancing outcomes for individuals dealing with chronic pain conditions. Through this study, the investigators aim to explore the effectiveness of these interventions in targeting key variables such as pain perception, motor coordination, and overall quality of life, building on existing evidence of motor imagery's benefits in pain management.

Conditions

  • Motor Imagery Training

Interventions

BEHAVIORAL

Motor Imagery Plus Therapeutic Exercise

This group will perform three days of lumbo-pelvic motor control exercise intervention along with a motor imagery intervention program during active breaks between exercises.

BEHAVIORAL

Therapeutic Exercise

This group will perform a lumbo-pelvic motor control exercise program for three consecutive days.

BEHAVIORAL

Minimal intervention

This group will carry out a therapeutic counseling and minimal education intervention during a one-day intervention.

Sponsors & Collaborators

  • University of Valencia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-09
Primary Completion
2026-04-30
Completion
2026-05-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06674655 on ClinicalTrials.gov